We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Microwave Radiation Promising for Breast Cancer

By HospiMedica staff writers
Posted on 14 Oct 2002
In a phase II trial, microwave radiation focused externally on the breast resulted in significant tumor kill in a majority of patients. More...
The results were reported in the May 2002 issue of the Annals of Surgical Oncology.

The technology was invented by Dr. Alan J. Fenn, a senior staff member at the Lincoln Laboratory of the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA). Dr. Fenn realized that the same focused microwave technology used for missile detection could perhaps be used to treat breast cancer cells. A new randomized clinical trial enrolling 220 women has already begun.

The microwave thermotherapy technology was licensed to Celsion Corp. (Columbia, MD, USA) which developed the clinical system and is now funding the clinical studies. Celsion calls the system Adaptive Phased Array Thermotherapy. Treatment takes only about 60 minutes. The focused microwaves generate heat, which shrinks large tumors and kills small ones. The goal of the therapy is to kill tumor cells and reduce additional surgery.




Related Links:
Celsion

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.